Gene fusion reduces NSCLC patient survival
ROS1 fusions predict a poor outcome in Chinese patients with non-small-cell lung cancer, study findings suggest.
Source: MedWire News - Respiratory - Category: Respiratory Medicine Source Type: news
More News: Cancer | Cancer & Oncology | Genetics | Lung Cancer | Non-Small Cell Lung Cancer | Respiratory Medicine | Study